Biotech Stocks Get A Turbo Boost From Idenix Deal
Rally Retraces Correction Up To Mid-Point YTD Up until this week we have focused on large cap biopharmaceuticals because of revenue momentum, fair valuations and earnings. A risk -off sentiment due to lack of ASCO buzz and the Q1 speculative bubble downdraft has curbed gains. This week with...
Look For Biotech Rally Today Sparked By Merck $3.9B Acquisition of Idenix… Update-1
Update-1.... 45 Minutes Before the Close 6/9...Risk On Biotech stocks soared today right at the open after news of $3.9B Idenix deal news was out. The XBI was up 5.4% on good volume. The XBI is more equal weighted and sensitive to mid and small cap stock moves.The PBE another more speculative...
ASCO Oncology Stocks: Recap and Scoreboard- AGIO, MDVN, SGEN Winners
High Profile Biotechnology Companies with ASCO Presence Investors and traders waited toward the end of the ASCO Annual Meeting week to buy their favorite stocks. The biotech sector overall was boosted after the close of the meeting after a brief sell-off on June 2 and 3. Most biopharmaceutical...
Clinical Tools and Diagnostic Companies:Financial Metrics 2014 Q1Results
Clinical Diagnostic Stocks Were Hit By Bio-Bubble or Revenue Miss Potential upside in EXAS, NSTG and NEOG all are Rayno Dx and Tools picks. With "momentum trading" days over for now, revenue growth is the focus. Companies with disappointing Q1 revenues: Abaxis (ABAX), Alere (ALR), Response...
ASCO Update #4- No Boost For Oncology Stocks… Update-6/4 MDVN, PCYC, SGEN
Update 6/4 Snap- back rally and big green screen! Update 6/3..... Daily Performance-from list below 9 winners, 12 losers Rayno Biopharmaceutical Picks in bold--- Winners: AGIO, INCY, SGEN, EPZM, MDVN, IMGN, GILD. CELG, PCYC. Losers: CLVS, ARIA, NLNK,CLDX, BLUE, LBIO, PBYI, KPTI, BMY, AZN,...